Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit

17 Oct 2023

Abstract excerpt

A summit held March 2023 in Scottsdale, Arizona (USA) focused on the intronic hexanucleotide expansion in the C9ORF72 gene and its relevance in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS; C9ORF72-FTD/ALS). The goal of this summit was to connect basic scientists, clinical researchers, drug developers, and individuals affected by C9ORF72-FTD/ALS to evaluate how collaborative efforts across...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Neurogenetic and Muscular Disorders Research
Share to Prion Diseases and Protein Misfolding

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37847372
DOI: 10.1007/s40120-023-00548-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS SummitPMID 37847372Read ↗

Expanding Clinical Spectrum of C9ORF72 -Related Disorders and Promising Therapeutic StrategiesSemantic proximity Read ↗

C9ORF72 mutations in neurodegenerative diseases.Semantic proximity Read ↗

How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?Semantic proximity Read ↗

Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansionSemantic proximity Read ↗

Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.Semantic proximity Read ↗

C9ORF72 hexanucleotide repeat expansion: From ALS and FTD to a broader pathogenic role?Semantic proximity Read ↗

Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72Semantic proximity Read ↗

Development of Therapeutics for C9ORF72 ALS/FTD-Related DisordersSemantic proximity Read ↗

CRISPR/Cas9-Mediated Excision of ALS/FTD-Causing Hexanucleotide Repeat Expansion in <i>C9ORF72</i> rescues major disease mechanisms <i>in vivo</i> and <i>in vitro</i>Semantic proximity Read ↗

Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72Semantic proximity Read ↗

C9orf72 hexanucleotide repeat expansions as the causative mutation for chromosome 9p21-linked amyotrophic lateral sclerosis and frontotemporal dementia.Semantic proximity Read ↗

Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.